eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | non-alcoholic fatty liver disease |
| Comorbidity | C0019204|hepatocellular carcinoma |
| Sentences | 13 |
| PubMedID- 22576780 | Background: non-alcoholic fatty liver disease (nafld) can lead to cirrhosis and hepatocellular carcinoma and is strongly associated with obesity and insulin resistance. |
| PubMedID- 25694178 | We review the role of liver ultrasonography (us) and related techniques as non-invasive tools in predicting metabolic derangements, liver histology, portal hypertension and cardiovascular risk as well as allowing early diagnosis and management of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease. |
| PubMedID- 22678663 | There are limited therapeutic options for permanently ameliorating hepatic steatosis [18, 19] and there are no methods for reversing hepatic fibrosis, or preventing hepatocellular carcinoma due to nafld [20]. |
| PubMedID- 26202505 | Value of shear wave velocity measurements for the risk assessment of hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease : hcc risk assessment by vttq. |
| PubMedID- 26250831 | hepatocellular carcinoma in the setting of non-cirrhotic nonalcoholic fatty liver disease and the metabolic syndrome: us experience. |
| PubMedID- 25556679 | There are limited therapeutic options for permanently ameliorating hepatic steatosis and there are no methods for reversing hepatic fibrosis, or preventing hepatocellular carcinoma due to nafld [12]. |
| PubMedID- 25744657 | Purpose: the incidence of hepatocellular carcinoma (hcc) in patients with nonalcoholic fatty liver disease (nafld) is increasing. |
| PubMedID- 23905912 | Objectives: the incidence of hepatocellular carcinoma associated with nonalcoholic fatty liver disease is increasing. |
| PubMedID- 26274335 | Association of nonalcoholic fatty liver disease (nafld) with hepatocellular carcinoma (hcc) in the united states from 2004 to 2009. |
| PubMedID- 20170634 | Given that nafld may lead to hepatocellular carcinoma [14,15], it is conceivable that the rising rates of pancreatic adenocarcinoma may, by extrapolation from nafld, be secondary to nafpd. |
| PubMedID- 26473344 | Nonalcoholic fatty liver disease (nafld) can lead to cirrhosis, hepatocellular carcinoma, and ultimately death. |
| PubMedID- 23394097 | However, whether aat mutations predispose to hepatocellular carcinoma in patients with nafld remains to be evaluated. |
| PubMedID- 24251711 | In japan, there has been a gradual increase in cases of non-viral chronic liver diseases, including non-alcoholic fatty liver disease (nafld), occurring with hepatocellular carcinoma (hcc). |
Page: 1